Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
amyloidosis
,
familial amyloid neuropathies
,
pregnancy
Pelacarsen
renal insufficiency
,
healthy volunteers/patients
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
hypertriglyceridemia
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
hyperlipoproteinemias
,
homozygous familial hypercholesterolemia
Endocrine
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
lung neoplasms
,
head and neck neoplasms
,
neoplasms by site
,
medullary carcinoma
,
brain neoplasms
,
thyroid neoplasms
,
respiratory tract diseases
,
central nervous system neoplasms
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
colonic neoplasms
,
papillary thyroid cancer
,
endocrine gland neoplasms
,
thyroid diseases
,
bronchial neoplasms
,
melanoma
,
sarcoma
,
myofibromatosis
,
ovarian neoplasms
,
endometrial neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
breast diseases
,
hereditary sensory and autonomic neuropathies
,
obesity
,
body weight
,
nutrition disorders
,
overnutrition
,
type 2 diabetes mellitus
,
endocrine system diseases
,
diabetes mellitus
,
glucose metabolism disorders
,
metabolic diseases
,
male breast neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
breast neoplasms
,
neoplasms
,
neoplasm metastasis
,
triple negative breast neoplasms
,
type 1 diabetes mellitus
,
growth disorders
,
dwarfism
Trinessa
infections
,
acquired immunodeficiency syndrome
,
asthma
,
bacterial infections
,
type 2 diabetes mellitus
,
renal cell carcinoma
,
neoplasms
,
human influenza
,
healthy volunteers/patients
,
anemia
,
respiratory tract infections
,
acute coronary syndrome
,
embryo transfer
,
vivax malaria
,
premature obstetric labor
,
premature birth
,
vomiting
,
nausea
,
alzheimer disease
,
diabetes mellitus
,
atrial fibrillation
,
atherosclerosis
,
pulmonary tuberculosis
,
tuberculosis
,
lung diseases
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
Fluoroquinolone
healthy volunteers/patients
Thienopyridine
healthy volunteers/patients
,
acute coronary syndrome
,
coronary artery disease
,
atherosclerosis
,
percutaneous coronary intervention
,
myocardial infarction
,
st elevation myocardial infarction
,
non-st elevated myocardial infarction
Tqj230
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use